IgG from atopic dermatitis patients induces IL-17 and IL-10 production in infant intrathymic TCD4 and TCD8 cells
Carregando...
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
OLIVEIRA, Marilia G. de
TITZ, Tiago O.
BENTO-DE-SOUZA, Luciana
Citação
INTERNATIONAL JOURNAL OF DERMATOLOGY, v.57, n.4, p.434-440, 2018
Resumo
IntroductionOur group recently demonstrated that IgG modulates T cell cytokine production during the maturation process in the human thymus. The effects of this modulation are IgG repertoire dependent and can exert a systemic and long-term impact. ObjectiveTo investigate whether IgG from atopic dermatitis (AD) patients can modulate cytokine production of infant intrathymic TCD4 and TCD8 cells in vitro. MethodsThymic tissues were obtained from newborn children from nonatopic mothers, and thymocytes were cultured for 6 days with purified IgG from AD patients or with intravenous immunoglobulin (IVIG) or mock conditions as controls. Cells were gated as double positive T cells (TDP(-)CD4(+)CD8(+)), TCD4 cells (CD4(+)CD8(-)), or TCD8 cells (CD4(-)CD8(+)), and intracellular levels of IL-17A, IFN-, TNF-, IL-4, IL-10, and TGF- were evaluated by flow cytometry. ResultsCompared to mock and IVIG culture conditions, IgG of AD individuals induced in vitro intracellular production of IL-17 and IL-10 by intrathymic TDP, TCD4, and TCD8 cells of infants. TGF- was also detected at a higher frequency in response to AD IgG in TDP and TCD8 cells compared to mock and IVIG cultured conditions. An opposite effect was detected upon IFN- production in TCD4 cells, such that AD IgG reduced IFN- production compared to production under mock conditions but not under IVIG conditions. ConclusionIgG of AD patients can stimulate cytokine production in infant thymocytes and thus resembles the peripheral profile observed in adults. These findings suggest a novel mechanism that can contribute to AD pathogenesis.
Palavras-chave
Referências
- Batista DIS, 2015, J EUR ACAD DERMATOL, V29, P1091, DOI 10.1111/jdv.12753
- Belderbos ME, 2012, CLIN EXP ALLERGY, V42, P66, DOI 10.1111/j.1365-2222.2011.03857.x
- Bento-de-Souza Luciana, 2016, Results Immunol, V6, P15, DOI 10.1016/j.rinim.2016.04.001
- Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P941, DOI 10.1016/j.jaci.2015.05.049
- Sgnotto FD, 2017, HUM VACC IMMUNOTHER, V13, P1563, DOI 10.1080/21645515.2017.1299299
- Lira AAD, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-47
- de Oliveira MG, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0195-8
- de Saint-Vis B, 1998, J IMMUNOL, V160, P1666
- Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013
- Fusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865
- Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x
- Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x
- Futata EA, 2006, IMMUNOBIOLOGY, V211, P157, DOI 10.1016/j.imbio.2005.08.006
- Gurkan A, 2016, ACTA DERMATOVENER CR, V24, P268
- Hamel Y, 2016, J AUTOIMMUN, V73, P54, DOI 10.1016/j.jaut.2016.06.003
- Han SC, 2015, J INVEST DERMATOL, V135, P1556, DOI 10.1038/jid.2014.488
- Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x
- Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016
- JARRETT EEE, 1983, IMMUNOLOGY, V48, P49
- Jenmalm MC, 2000, CLIN EXP ALLERGY, V30, P34, DOI 10.1046/j.1365-2222.2000.00771.x
- Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017
- Kim HS, 2015, STEM CELLS, V33, P1254, DOI 10.1002/stem.1913
- Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111
- Lemieux W, 2005, MOL IMMUNOL, V42, P839, DOI 10.1016/j.molimm.2004.07.046
- Lesiak A, 2014, ARCH MED SCI, V10, P1239, DOI 10.5114/aoms.2014.47833
- Li J, 2015, PROCEEDINGS 3RD IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION ACPR 2015, P1, DOI 10.1109/ACPR.2015.7486454
- Ma L, 2014, J EUR ACAD DERMATOL, V28, P1079, DOI 10.1111/jdv.12288
- Martel BC, 2016, INFLAMM RES, V65, P265, DOI 10.1007/s00011-015-0912-z
- Muniz BP, 2014, IMMUNOBIOLOGY, V219, P377, DOI 10.1016/j.imbio.2014.01.002
- Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015
- Oliveira CR, 2005, J CLIN IMMUNOL, V25, P153, DOI 10.1007/s10875-005-2821-3
- Rigato PO, 2009, IMMUNOTHERAPY, V1, P141, DOI [10.2217/1750743X.1.1.141, 10.2217/1750-743X.1.1.141]
- Sato M. N., 2002, Clinical and Experimental Allergy, V32, P1667, DOI 10.1046/j.1365-2222.2002.01429.x
- Sato MN, 2001, J INTERF CYTOK RES, V21, P827, DOI 10.1089/107999001753238079
- Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076
- Seneviratne SL, 2006, CLIN EXP DERMATOL, V31, P689, DOI 10.1111/j.1365-2230.2006.02172.x
- Simon D, 2007, BRIT J DERMATOL, V157, P583, DOI 10.1111/j.1365-2133.2007.08050.x
- Stach SCL, 2014, AM J REPROD IMMUNOL, V72, P555, DOI 10.1111/aji.12305
- Tan Q, 2017, J CUTAN MED SURG, V21, P308, DOI 10.1177/1203475417697651
- Vance GHS, 2004, CLIN EXP ALLERGY, V34, P1855, DOI 10.1111/j.1365-2222.2004.02111.x
- VANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985
- Victor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11
- Victor JR, 2017, HUM VACC IMMUNOTHER, V13, P507, DOI 10.1080/21645515.2016.1244592
- Victor JR, 2014, J IMMUNOL RES, DOI 10.1155/2014/780386
- Victor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39
- Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291
- WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
- Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X
- Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308
- Wu KH, 2006, PEDIATR ALLERGY IMMU, V17, P60, DOI 10.1111/j.1399-3038.2005.00344.x